XML 17 R7.htm IDEA: XBRL DOCUMENT v3.23.3
Consolidated Statement of Stockholders' Equity - USD ($)
shares in Millions, $ in Millions
Total
Common Stock [Member]
Capital in Excess of Par Value [Member]
Retained Earnings [Member]
Accumulated Other Comprehensive Loss [Member]
Noncontrolling Interests [Member]
Beginning balance at Dec. 31, 2021 $ 8,560.1 $ 208.5 $ 6,143.7 $ 2,882.3 $ (726.1) $ 51.7
Beginning balance (in shares) at Dec. 31, 2021   208.5        
Net earnings 439.1     438.7   0.4
Net purchase of subsidiary shares from noncontrolling interests 2.1         2.1
Dividends paid to noncontrolling interests (0.6)         (0.6)
Net change in pension asset/liability, net of taxes 0.3       0.3  
Foreign currency translation 15.0       14.9 0.1
Change in fair value of derivative instruments, net of taxes 45.2       45.2  
Compensation expense related to stock option plan grants 5.7   5.7      
Stock option plans 37.8 $ 0.7 37.1      
Stock option plans (in shares)   0.7        
Employee stock purchase plan 8.1 $ 0.1 8.0      
Employee stock purchase plan (in shares)   0.1        
Shares issued to benefit plans 74.4 $ 0.5 73.9      
Shares issued to benefit plans (in shares)   0.5        
Deferred compensation and restricted stock (36.1) $ 0.3 (36.4)      
Deferred compensation and restricted (in shares)   0.3        
Cash dividends declared on common stock (108.0)     (108.0)    
Ending balance at Mar. 31, 2022 9,043.1 $ 210.1 6,232.0 3,213.0 (665.7) 53.7
Ending balance, (in shares) at Mar. 31, 2022   210.1        
Beginning balance at Dec. 31, 2021 8,560.1 $ 208.5 6,143.7 2,882.3 (726.1) 51.7
Beginning balance (in shares) at Dec. 31, 2021   208.5        
Net earnings 980.5          
Change in fair value of derivative instruments, net of taxes 49.3          
Compensation expense related to stock option plan grants 20.4          
Ending balance at Sep. 30, 2022 8,629.1 $ 210.8 6,305.5 3,536.2 (1,478.7) 55.3
Ending balance, (in shares) at Sep. 30, 2022   210.8        
Beginning balance at Mar. 31, 2022 9,043.1 $ 210.1 6,232.0 3,213.0 (665.7) 53.7
Beginning balance (in shares) at Mar. 31, 2022   210.1        
Net earnings 285.1     284.2   0.9
Net purchase of subsidiary shares from noncontrolling interests (1.0)         (1.0)
Dividends paid to noncontrolling interests (0.4)         0.4
Net change in pension asset/liability, net of taxes (0.3)       (0.3)  
Foreign currency translation (418.0)       (417.9) (0.1)
Change in fair value of derivative instruments, net of taxes 26.6       26.6  
Compensation expense related to stock option plan grants 7.2   7.2      
Stock option plans 10.6 $ 0.2 10.4      
Stock option plans (in shares)   0.2        
Employee stock purchase plan 12.5   12.5      
Deferred compensation and restricted stock 4.9   4.9      
Cash dividends declared on common stock (108.5)     (108.5)    
Ending balance at Jun. 30, 2022 8,861.8 $ 210.3 6,267.0 3,388.7 (1,057.3) 53.1
Ending balance, (in shares) at Jun. 30, 2022   210.3        
Net earnings 256.3     255.8   0.5
Net purchase of subsidiary shares from noncontrolling interests 2.9         2.9
Dividends paid to noncontrolling interests (1.0)         1.0
Foreign currency translation (399.1)       (398.9) (0.2)
Change in fair value of derivative instruments, net of taxes (22.5)       (22.5)  
Compensation expense related to stock option plan grants 7.5   7.5      
Common stock issued in: purchase transactions 17.3 $ 0.1 17.2      
Common stock issued in: purchase transactions (in shares)   0.1        
Stock option plans 15.8 $ 0.3 15.5      
Stock option plans (in shares)   0.3        
Employee stock purchase plan 17.3 $ 0.1 17.2      
Employee stock purchase plan (in shares)   0.1        
Deferred compensation and restricted stock (18.9)   (18.9)      
Cash dividends declared on common stock (108.3)     (108.3)    
Ending balance at Sep. 30, 2022 8,629.1 $ 210.8 6,305.5 3,536.2 (1,478.7) 55.3
Ending balance, (in shares) at Sep. 30, 2022   210.8        
Beginning balance at Dec. 31, 2022 $ 9,190.2 $ 211.9 6,509.9 3,562.2 (1,140.4) 46.6
Beginning balance (in shares) at Dec. 31, 2022 211.9 211.9        
Net earnings $ 486.6     486.5   0.1
Net purchase of subsidiary shares from noncontrolling interests (5.4)         (5.4)
Dividends paid to noncontrolling interests (0.7)         (0.7)
Net change in pension asset/liability, net of taxes 0.8       0.8  
Foreign currency translation 33.2       33.3 (0.1)
Change in fair value of derivative instruments, net of taxes 4.9       4.9  
Compensation expense related to stock option plan grants 7.7   7.7      
Common stock issued in: purchase transactions 186.5 $ 1.0 185.5      
Common stock issued in: purchase transactions (in shares)   1.0        
Stock option plans 21.2 $ 0.5 20.7      
Stock option plans (in shares)   0.5        
Employee stock purchase plan 9.1 $ 0.1 9.0      
Employee stock purchase plan (in shares)   0.1        
Shares issued to benefit plans 84.6 $ 0.4 84.2      
Shares issued to benefit plans (in shares)   0.4        
Deferred compensation and restricted stock (41.9) $ 0.3 (42.2)      
Deferred compensation and restricted (in shares)   0.3        
Cash dividends declared on common stock (118.5)     (118.5)    
Ending balance at Mar. 31, 2023 9,858.3 $ 214.2 6,774.8 3,930.2 (1,101.4) 40.5
Ending balance, (in shares) at Mar. 31, 2023   214.2        
Beginning balance at Dec. 31, 2022 $ 9,190.2 $ 211.9 6,509.9 3,562.2 (1,140.4) 46.6
Beginning balance (in shares) at Dec. 31, 2022 211.9 211.9        
Net earnings $ 1,005.6          
Net change in pension asset/liability, net of taxes 2.3          
Change in fair value of derivative instruments, net of taxes 63.0          
Compensation expense related to stock option plan grants $ 24.6          
Stock option plans (in shares) 1.1          
Ending balance at Sep. 30, 2023 $ 10,510.0 $ 215.9 7,106.4 4,205.7 (1,064.5) 46.5
Ending balance, (in shares) at Sep. 30, 2023 215.9 215.9        
Beginning balance at Mar. 31, 2023 $ 9,858.3 $ 214.2 6,774.8 3,930.2 (1,101.4) 40.5
Beginning balance (in shares) at Mar. 31, 2023   214.2        
Net earnings 235.8     234.5   1.3
Net purchase of subsidiary shares from noncontrolling interests 2.7         2.7
Dividends paid to noncontrolling interests (0.5)         (0.5)
Net change in pension asset/liability, net of taxes 0.7       0.7  
Foreign currency translation 193.8       193.5 0.3
Change in fair value of derivative instruments, net of taxes 24.3       24.3  
Compensation expense related to stock option plan grants 7.8   7.8      
Common stock issued in: purchase transactions 178.6 $ 0.8 177.8      
Common stock issued in: purchase transactions (in shares)   0.8        
Stock option plans 22.8 $ 0.4 22.4      
Stock option plans (in shares)   0.4        
Employee stock purchase plan 13.0 $ 0.1 12.9      
Employee stock purchase plan (in shares)   0.1        
Deferred compensation and restricted stock 22.3   22.3      
Cash dividends declared on common stock (119.6)     (119.6)    
Ending balance at Jun. 30, 2023 10,440.0 $ 215.5 7,018.0 4,045.1 (882.9) 44.3
Ending balance, (in shares) at Jun. 30, 2023   215.5        
Net earnings 283.2     280.7   2.5
Net purchase of subsidiary shares from noncontrolling interests 0.3         0.3
Dividends paid to noncontrolling interests (1.1)         (1.1)
Net change in pension asset/liability, net of taxes 0.8       0.8  
Foreign currency translation (215.7)       (216.2) 0.5
Change in fair value of derivative instruments, net of taxes 33.8       33.8  
Compensation expense related to stock option plan grants 9.1   9.1      
Common stock issued in: purchase transactions 23.3 $ 0.1 23.2      
Common stock issued in: purchase transactions (in shares)   0.1        
Stock option plans 12.3 $ 0.2 12.1      
Stock option plans (in shares)   0.2        
Employee stock purchase plan 21.7 $ 0.1 21.6      
Employee stock purchase plan (in shares)   0.1        
Deferred compensation and restricted stock 22.4   22.4      
Cash dividends declared on common stock (120.1)     (120.1)    
Ending balance at Sep. 30, 2023 $ 10,510.0 $ 215.9 $ 7,106.4 $ 4,205.7 $ (1,064.5) $ 46.5
Ending balance, (in shares) at Sep. 30, 2023 215.9 215.9